Raporty Spółek ESPI/EBI

Preliminary sales revenue data for July 2026 SOPHARMA AD (BG11SOSOBT18)

20-08-2026 14:19:19 | ESPI | 224/2026
oUNI-EN: Preliminary sales revenue data for July 2026

 PAP
Data: 2026-08-20
Firma: SOPHARMA AD
oSpis tresci:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • INSIDE_SFA_July_2026_Sales_20082026_EN.rar
    		•  Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 224 / 2026
    Date of issue: 2026-08-20
    Short name of the issuer
    SOPHARMA AD
    Subject
    Preliminary sales revenue data for July 2026
    Official market - legal basis
    Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
    Unofficial market - legal basis
    Contents of the report:
    Sofia, Bulgaria, August 20, 2026 - "Sopharma" AD _SFA: "Bulgarian Stock Exchange" AD, SPH: Warsaw Stock Exchange_ pursuant to the requirements of art. 100t of the Law on Public Offering of Securities _LPOS_, hereby informs that in July 2026 the Company reported a 103% increase in sales compared to the same month of the previous year, including a 31% increase in domestic sales and a 151% increase in export sales.
    For the period from the beginning of 2026 through the end of July, the Company reported a 52% increase in sales compared to the same period of the previous year, including a 2% increase in domestic sales and an 82% increase in export sales.
    Annexes
    File Description
    INSIDE_SFA_July_2026_Sales_20082026_EN.rar Preliminary sales revenue data for July 2026

    Nazwa arkusza: ESAP METADATE


    Legal framework Type of information
    TRANSD Inside information
    RegulatoryData
    Collection Body PLKNF
    Unique data record identifier
    Type of submission Correction _to be used when information previously reported is found to be incorrect and should be corrected_
    Voluntary information flag
    Date or period covered [Date or beginning of the period to which the information relates] 2026-07-01
    Date or period covered [Date or end of the period to which the information relates] 2026-07-31
    Personal data flag
    Macierzyste państwo członkowskie, w stosownych przypadkach PL
    DocumentReference
    Język, w którym przekazano informacje Oryginał _ORIG_ czy tłumaczenie _TRAN_ Numer referencyjny pliku danych
    PL ORIG
    SubmittingEntity
    Submitting entity LEI or Submitting entity name - natural person
    RelatedEntity/LegalPerson
    Entity LEI Size of the entity Industry sector_s_
    097900BGGW0000048796 Large undertaking _acc. NACE_: C

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    SOPHARMA AD
    _fullname of the issuer_
    SOPHARMA AD Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    1220 Sofia
    _post code_ _city_
    IlienskoShosse 16
    _street_ _number_
    +359 2 813 42 00 +359 2 936 02 86
    _phone number_ _fax_
    _e-mail_ _web site_
    nd
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-08-20 Ognian Ivanov Donev Executive Director


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta SOPHARMA AD
    Symbol Emitenta SOPHARMA AD
    Tytul Preliminary sales revenue data for July 2026
    Sektor Farmaceutyczny (far)
    Kod 1220
    Miasto Sofia
    Ulica IlienskoShosse
    Nr 16
    Tel. +359 2 813 42 00
    Fax +359 2 936 02 86
    e-mail
    NIP nd
    REGON
    Data sporzadzenia 2026-08-20
    Rok biezacy 2026
    Numer 224
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.